Moreover, the characterization of a recombinant immunotoxin (GnRH-DNA fragmentation factor 40) for targeted therapy of BC cells (SKBR-3, MDA-MB-231, MCF-7) expressing GnRH receptors has been published [99]. The gene discussed is GNRHR; the disease is breast cancer.